rs182465294
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The ENST00000372325.7(SFTPA2):c.292+11C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00456 in 1,613,858 control chromosomes in the GnomAD database, including 44 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0099 ( 12 hom., cov: 32)
Exomes 𝑓: 0.0040 ( 32 hom. )
Consequence
SFTPA2
ENST00000372325.7 intron
ENST00000372325.7 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.633
Genes affected
SFTPA2 (HGNC:10799): (surfactant protein A2) This gene is one of several genes encoding pulmonary-surfactant associated proteins (SFTPA) located on chromosome 10. Mutations in this gene and a highly similar gene located nearby, which affect the highly conserved carbohydrate recognition domain, are associated with idiopathic pulmonary fibrosis. The current version of the assembly displays only a single centromeric SFTPA gene pair rather than the two gene pairs shown in the previous assembly which were thought to have resulted from a duplication. [provided by RefSeq, Sep 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.74).
BP6
Variant 10-79558875-G-A is Benign according to our data. Variant chr10-79558875-G-A is described in ClinVar as [Benign]. Clinvar id is 227068.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00986 (1499/152050) while in subpopulation AFR AF= 0.0252 (1046/41454). AF 95% confidence interval is 0.024. There are 12 homozygotes in gnomad4. There are 715 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 1499 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SFTPA2 | NM_001098668.4 | c.292+11C>T | intron_variant | ENST00000372325.7 | NP_001092138.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SFTPA2 | ENST00000372325.7 | c.292+11C>T | intron_variant | 1 | NM_001098668.4 | ENSP00000361400 | P1 | |||
SFTPA2 | ENST00000372327.9 | c.292+11C>T | intron_variant | 1 | ENSP00000361402 | P1 | ||||
SFTPA2 | ENST00000417041.1 | c.292+11C>T | intron_variant | 5 | ENSP00000397375 | |||||
SFTPA2 | ENST00000492049.1 | downstream_gene_variant | 5 | ENSP00000473275 |
Frequencies
GnomAD3 genomes AF: 0.00979 AC: 1488AN: 151932Hom.: 12 Cov.: 32
GnomAD3 genomes
AF:
AC:
1488
AN:
151932
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00557 AC: 1401AN: 251330Hom.: 6 AF XY: 0.00549 AC XY: 746AN XY: 135846
GnomAD3 exomes
AF:
AC:
1401
AN:
251330
Hom.:
AF XY:
AC XY:
746
AN XY:
135846
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00401 AC: 5860AN: 1461808Hom.: 32 Cov.: 70 AF XY: 0.00419 AC XY: 3050AN XY: 727206
GnomAD4 exome
AF:
AC:
5860
AN:
1461808
Hom.:
Cov.:
70
AF XY:
AC XY:
3050
AN XY:
727206
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00986 AC: 1499AN: 152050Hom.: 12 Cov.: 32 AF XY: 0.00962 AC XY: 715AN XY: 74356
GnomAD4 genome
AF:
AC:
1499
AN:
152050
Hom.:
Cov.:
32
AF XY:
AC XY:
715
AN XY:
74356
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 16, 2016 | c.292+11C>T in intron 4 of SFTPA2: This variant is not expected to have clinical significance because it is not located within the splice consensus sequence. I t has been identified in 2.7% (278/10396) of African chromosomes including 2 hom ozygotes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.o rg; dbSNP rs182465294). - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at